Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.2200
+0.3400
+(38.64%)
At close: February 26 at 9:55:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-28,604
-38,972
4,043
-28,647
-9,307
Investing Cash Flow
-7,183
-17,635
9,346
-43,545
-502
Financing Cash Flow
-198
-571
283
151,160
18,969
End Cash Position
26,678
44,231
100,333
90,869
15,818
Interest Paid Supplemental Data
-72
--
97
224
--
Capital Expenditure
-23
-730
-587
-764
-502
Issuance of Capital Stock
--
--
--
155,987
22,025
Issuance of Debt
--
470
611
680
2,033
Repayment of Debt
-695
-1,041
-343
-340
-240
Repurchase of Capital Stock
--
--
--
-5,167
-4,849
Free Cash Flow
-28,627
-39,702
3,456
-29,411
-9,809
12/31/2020 - 4/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRXBF NUREXONE BIOLOGIC INC
0.3960
-5.71%
OSE.PA OSE Immunotherapeutics SA
6.64
+0.15%
AKTX Akari Therapeutics, Plc
0.9201
+1.11%
SLGL Sol-Gel Technologies Ltd.
0.5550
+0.91%
SYRE Spyre Therapeutics, Inc.
19.00
-7.99%
UPB Upstream Bio, Inc.
7.66
-0.91%
BOLT Bolt Biotherapeutics, Inc.
0.4600
-3.10%
XNCR Xencor, Inc.
14.38
-0.48%
PRLD Prelude Therapeutics Incorporated
0.8084
+0.30%
APRE Aprea Therapeutics, Inc.
2.5500
-0.39%